356 related articles for article (PubMed ID: 21980926)
1. The potential role of Aurora kinase inhibitors in haematological malignancies.
Farag SS
Br J Haematol; 2011 Dec; 155(5):561-79. PubMed ID: 21980926
[TBL] [Abstract][Full Text] [Related]
2. ENMD-2076 for hematological malignancies.
How J; Yee K
Expert Opin Investig Drugs; 2012 May; 21(5):717-32. PubMed ID: 22397360
[TBL] [Abstract][Full Text] [Related]
3. Aurora kinase inhibitors: progress towards the clinic.
Kollareddy M; Zheleva D; Dzubak P; Brahmkshatriya PS; Lepsik M; Hajduch M
Invest New Drugs; 2012 Dec; 30(6):2411-32. PubMed ID: 22350019
[TBL] [Abstract][Full Text] [Related]
4. Aurora kinase inhibitors as anticancer molecules.
Katayama H; Sen S
Biochim Biophys Acta; 2010; 1799(10-12):829-39. PubMed ID: 20863917
[TBL] [Abstract][Full Text] [Related]
5. Evolution of resistance to Aurora kinase B inhibitors in leukaemia cells.
Failes TW; Mitic G; Abdel-Halim H; Po'uha ST; Liu M; Hibbs DE; Kavallaris M
PLoS One; 2012; 7(2):e30734. PubMed ID: 22359551
[TBL] [Abstract][Full Text] [Related]
6. Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias.
Moore AS; Blagg J; Linardopoulos S; Pearson AD
Leukemia; 2010 Apr; 24(4):671-8. PubMed ID: 20147976
[TBL] [Abstract][Full Text] [Related]
7. Targeting aurora kinases in cancer treatment.
Kelly KR; Ecsedy J; Mahalingam D; Nawrocki ST; Padmanabhan S; Giles FJ; Carew JS
Curr Drug Targets; 2011 Dec; 12(14):2067-78. PubMed ID: 21777198
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies.
Teachey DT; Grupp SA; Brown VI
Br J Haematol; 2009 Jun; 145(5):569-80. PubMed ID: 19344392
[TBL] [Abstract][Full Text] [Related]
9. Aurora-B kinase inhibitors for cancer chemotherapy.
Yeung SC; Gully C; Lee MH
Mini Rev Med Chem; 2008 Dec; 8(14):1514-25. PubMed ID: 19075809
[TBL] [Abstract][Full Text] [Related]
10. Aurora kinase inhibitors in preclinical and clinical testing.
Cheung CH; Coumar MS; Hsieh HP; Chang JY
Expert Opin Investig Drugs; 2009 Apr; 18(4):379-98. PubMed ID: 19335272
[TBL] [Abstract][Full Text] [Related]
11. [Research progress on aurora kinase inhibitor MK-0457 in therapy for some hematological malignancies -- review].
Liang YQ; Chen BA; Chen YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):810-5. PubMed ID: 19549414
[TBL] [Abstract][Full Text] [Related]
12. Aurora kinases: new targets for cancer therapy.
Carvajal RD; Tse A; Schwartz GK
Clin Cancer Res; 2006 Dec; 12(23):6869-75. PubMed ID: 17145803
[TBL] [Abstract][Full Text] [Related]
13. PI3K as a target for therapy in haematological malignancies.
Khwaja A
Curr Top Microbiol Immunol; 2010; 347():169-88. PubMed ID: 20517718
[TBL] [Abstract][Full Text] [Related]
14. Aurora kinase inhibitor patents and agents in clinical testing: an update (2009-10).
Cheung CH; Coumar MS; Chang JY; Hsieh HP
Expert Opin Ther Pat; 2011 Jun; 21(6):857-84. PubMed ID: 21591849
[TBL] [Abstract][Full Text] [Related]
15. Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system.
Pérez Fidalgo JA; Roda D; Roselló S; Rodríguez-Braun E; Cervantes A
Clin Transl Oncol; 2009 Dec; 11(12):787-98. PubMed ID: 20045785
[TBL] [Abstract][Full Text] [Related]
16. Is there a future for Aurora kinase inhibitors for anticancer therapy?
Carpinelli P; Moll J
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649
[TBL] [Abstract][Full Text] [Related]
17. Update on aurora kinase inhibitors in gynecologic malignancies.
Tao X; Chon HS; Fu S; Kavanagh JJ; Hu W
Recent Pat Anticancer Drug Discov; 2008 Nov; 3(3):162-77. PubMed ID: 18991785
[TBL] [Abstract][Full Text] [Related]
18. A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.
Görgün G; Calabrese E; Hideshima T; Ecsedy J; Perrone G; Mani M; Ikeda H; Bianchi G; Hu Y; Cirstea D; Santo L; Tai YT; Nahar S; Zheng M; Bandi M; Carrasco RD; Raje N; Munshi N; Richardson P; Anderson KC
Blood; 2010 Jun; 115(25):5202-13. PubMed ID: 20382844
[TBL] [Abstract][Full Text] [Related]
19. Aurora kinase inhibitors.
Kitzen JJ; de Jonge MJ; Verweij J
Crit Rev Oncol Hematol; 2010 Feb; 73(2):99-110. PubMed ID: 19369091
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with aurora kinase inhibitors: a review.
Boss DS; Beijnen JH; Schellens JH
Oncologist; 2009 Aug; 14(8):780-93. PubMed ID: 19684075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]